Why Choose Private Prescription for Weight Management?
Private vs NHS Route: Wegovy Doses vs Mounjaro Access
The NHS route for accessing Wegovy doses vs Mounjaro involves GP referral to specialist weight management services, with waiting lists often exceeding 6 months and strict BMI criteria. Many patients find themselves caught in bureaucratic delays whilst their health concerns persist. Private prescription through EverydayMeds eliminates these barriers—our 3-minute clinical assessment connects you directly with qualified prescribers who can evaluate whether Wegovy or Mounjaro suits your individual circumstances.
Both treatments are prescription-only medicines requiring medical supervision, but private access means receiving the same MHRA-approved medications without institutional delays. Your prescriber reviews your medical history, current medications, and weight management goals to recommend the most appropriate option, whether that's Wegovy's established GLP-1 approach or Mounjaro's dual-receptor mechanism.
Wegovy Doses vs Mounjaro: Pricing Transparency
Understanding the cost difference between Wegovy doses vs Mounjaro helps informed decision-making. Wegovy follows a structured escalation: 0.25mg starter pens cost £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance 2.4mg dose at £209.99. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices.
Our bundle options provide convenience for longer treatment periods—the Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first 12 weeks of dose escalation. The Ultimate Stability Trio offers three months of maintenance 2.4mg supply for £649.99. These bundles ensure treatment continuity without repeated ordering, particularly valuable given the mandatory dose escalation schedule both medications require.
Clinical Evidence: Wegovy Doses vs Mounjaro Efficacy
The STEP clinical trials demonstrated Wegovy's efficacy across different populations—STEP 1 showed approximately 15% average weight loss at 68 weeks when used alongside diet and exercise, whilst STEP 2 achieved around 9.6% in patients with type 2 diabetes. The SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, highlighting benefits beyond weight management.
Mounjaro's SURPASS trials focused primarily on diabetes management, though weight loss was a consistent secondary outcome. When comparing Wegovy doses vs Mounjaro, both medications work through appetite regulation but via different pathways—direct comparison requires individual clinical assessment rather than generalised trial data, as study populations and endpoints varied significantly.
How Wegovy Works: GLP-1 Receptor Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. Once injected weekly, it binds to GLP-1 receptors in your brain's appetite centres, promoting satiety after smaller meals and potentially reducing food cravings. This mechanism explains why dose escalation is mandatory—starting at 0.25mg allows your body to adapt gradually, minimising gastrointestinal side effects whilst building therapeutic levels. The structured progression through 0.5mg, 1mg, and 1.7mg ultimately reaches the maintenance 2.4mg dose, where most patients experience optimal appetite regulation. Unlike oral medications that require daily compliance, Wegovy's once-weekly FlexTouch pen maintains consistent therapeutic levels throughout the week.
EverydayMeds Ordering Process
Accessing Wegovy doses vs Mounjaro through EverydayMeds begins with our 3-minute online clinical assessment, covering your medical history, current medications, and weight management goals. Our qualified prescribers—registered with GPhC #9012878—review your submission within 3 working days (24 hours with express service) to determine clinical suitability. Once approved, your prescription is dispensed from our registered UK pharmacy and dispatched via next-day cold-chain delivery to maintain medication integrity. Each package includes comprehensive patient information leaflets, injection guidance, and access to our clinical support team for ongoing queries. The entire process eliminates traditional pharmacy visits whilst ensuring full medical oversight and regulatory compliance.
Storage and Practical Considerations
Both Wegovy and Mounjaro require refrigerated storage at 2–8°C before first use, but Wegovy offers superior travel flexibility—6 weeks at room temperature below 30°C compared to Mounjaro's 21-day limit. This advantage proves valuable for business travel, holidays, or situations where refrigeration isn't consistently available. The FlexTouch pen design delivers precise doses through a simple click mechanism, with dose escalation preventing you from accidentally selecting higher strengths. Each pen provides 4 weekly injections, and the built-in needle safety system reduces injection anxiety for needle-phobic patients. Proper storage maintains medication potency throughout the treatment period, ensuring optimal therapeutic benefit.
Wegovy Doses vs Mounjaro: Mechanism Differences
The fundamental difference between Wegovy doses vs Mounjaro lies in their receptor targeting—Wegovy exclusively activates GLP-1 receptors, whilst Mounjaro combines GIP and GLP-1 agonism for dual-pathway appetite regulation. This distinction matters because individual patients may respond differently to single versus dual-receptor approaches. Some patients find Wegovy's established GLP-1 mechanism sufficient for their weight management goals, whilst others may benefit from Mounjaro's additional GIP pathway activation.
Your prescriber evaluates factors including previous medication responses, diabetes status, cardiovascular risk, and individual tolerance profiles when choosing between these mechanisms. Both require identical lifestyle modifications—reduced-calorie diet and increased physical activity—but the underlying pharmacology differs substantially. Neither approach is inherently superior; rather, the choice depends on your specific clinical presentation and treatment history.
Start Your Private Prescription Journey Today
Both Wegovy and Mounjaro are available through EverydayMeds' private prescription service, eliminating NHS delays whilst maintaining full clinical oversight. Our prescribers can help determine which treatment aligns with your weight management goals and medical profile. New customers use code FIRST40 at checkout, whilst returning customers apply DOSE25 to access competitive pricing. Begin your clinical assessment at https://everydaymeds.co.uk/collections/wegovy or contact our clinical team for personalised guidance. Remember, successful weight management requires long-term commitment alongside medication—our ongoing support ensures you maximise therapeutic benefits safely and effectively. Take the first step towards accessing professional weight management care without the barriers of traditional healthcare pathways.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
